Investment
Advancing Portfolio
Drug Development
.png "2016 Development of a novel mechanism-of-action antimalarial drug with multistage activity $1,999,993")
Vaccine Development
Diagnostic Development
*Disclaimer: The awarded amount refers to the conditional investment figure agreed at the initiation of each project.
As of 2018.12.13
As of 2018.12.13